Drugs Q & A

Why Triazolam Is Banned?

Triazolam is a medication belonging to the class of drugs known as benzodiazepines. It is primarily used to treat insomnia, a condition characterized by difficulty falling asleep or staying asleep. Triazolam is known by its brand name Halcion and is available in tablet form. Let’s delve into the history and development of triazolam:

Triazolam was first synthesized in the late 1970s by a team of chemists at the American pharmaceutical company Upjohn, now part of Pfizer. It was initially created as part of a research program to develop new benzodiazepines with improved sleep-inducing properties and a shorter duration of action. The research was driven by the need for effective treatments for insomnia that minimized the risk of residual sedation in the morning.

Triazolam, marketed as Halcion, received approval from the United States Food and Drug Administration (FDA) in 1982 for the treatment of insomnia. It quickly gained popularity as an effective sleep aid due to its rapid onset of action and relatively short half-life, which meant it could help individuals fall asleep more quickly without causing excessive grogginess the following morning. Triazolam became widely prescribed in the United States and other countries for the treatment of insomnia.

Why Triazolam Is Banned?

Since 1991, Triazolam (Halcion) has been listed among banned drugs in the United Kingdom, Brazil, Norway, Argentina, and Denmark because it causes excessive sedation and cognitive impairment in healthy elderly individuals compared to younger patients. Although Triazolam is not universally banned, its use has been significantly restricted in many countries due to concerns about its potential side effects and the risk of dependence. These restrictions and safety concerns have led to more cautious and limited use of the drug in clinical practice. The reasons for these restrictions and concerns include:

1.        Potential for Dependence: Triazolam, like other benzodiazepines, has the potential for physical and psychological dependence. Prolonged or excessive use can lead to tolerance, meaning higher doses are needed for the same effect, and withdrawal symptoms when discontinuing the drug. Dependence on benzodiazepines can be a significant concern for individuals.

2.        Memory and Cognitive Effects: Triazolam has been associated with memory disturbances, especially anterograde amnesia, where individuals have difficulty forming new memories after taking the drug. This can pose problems, particularly if people engage in activities after taking triazolam and then have no recollection of those events.

3.        Psychiatric Side Effects: Triazolam use has been linked to psychiatric side effects, including paradoxical reactions such as agitation, aggression, hallucinations, and confusion. These side effects can be unpredictable and distressing.

4.        Morning Hangover Effect: Although triazolam has a relatively short half-life, meaning it doesn’t stay in the body for an extended period, some individuals may still experience a “morning hangover” effect, where they feel groggy or impaired the morning after taking the medication.

5.        Regulatory Changes: In response to these concerns, regulatory agencies in some countries have taken action to modify the use of triazolam. For example, the United States Food and Drug Administration (FDA) revised the labeling for Halcion, added warnings about potential psychological and behavioral side effects, and recommended lower dosages to minimize risks.

It’s important to note that the status of triazolam varies from country to country. While it is not banned outright, healthcare providers are generally more cautious in prescribing it, and it is typically reserved for specific situations, such as short-term treatment of severe insomnia when other treatments have proven ineffective.

Individuals who are prescribed triazolam should use it under close medical supervision and be aware of the potential risks and side effects associated with the medication. Additionally, it is often recommended for short-term use, and healthcare providers should regularly assess the need for ongoing treatment.

Triazolam’s history is marked by its significant role in the treatment of insomnia, but also by the debates and regulatory changes surrounding its use. Today, it remains an option for those who require a rapid-acting sleep aid, but it is used with greater caution and awareness of its potential side effects and limitations.

Reducing The Risk Potential  While Taking Triazolam

Reducing the potential risks and side effects associated with medication, including drugs like triazolam, involves a combination of responsible use, close medical supervision, and lifestyle considerations. Here are some strategies to help minimize the potential risks and side effects:

1.        Medical Supervision:

•          Always use the medication as prescribed by your healthcare provider. Do not increase the dose or frequency without their guidance.

•          Maintain regular follow-up appointments with your healthcare provider to monitor your progress and discuss any concerns or side effects.

•          Inform your healthcare provider of your complete medical history, including any other medications, supplements, or medical conditions you have.

2.        Short-Term Use:

•          Triazolam is typically recommended for short-term use. Follow your healthcare provider’s instructions regarding the duration of treatment, and do not use it for longer than recommended.

3.        Lowest Effective Dose:

•          Start with the lowest effective dose, and only increase the dosage if advised by your healthcare provider.

•          Avoid taking higher doses than prescribed, as it increases the risk of side effects and dependence.

4.        Monitoring for Side Effects:

•          Be vigilant about monitoring yourself for any unusual or adverse reactions to the medication. If you experience unexpected side effects, contact your healthcare provider promptly.

5.        Avoid Alcohol and Other Sedatives:

•          Alcohol and other sedative substances can interact with triazolam and increase the risk of side effects. It’s important to avoid alcohol and discuss any other medications or substances you use with your healthcare provider.

6.        Appropriate Timing:

•          Take the medication as instructed, usually just before bedtime. This can help minimize the potential for daytime grogginess.

7.        Healthy Lifestyle Choices:

•          Maintain a healthy lifestyle that includes regular exercise, a balanced diet, and proper sleep hygiene practices.

•          Reducing stress through relaxation techniques such as meditation or deep breathing can also be beneficial.

8.        Tapering Off:

•          When your healthcare provider determines it’s time to stop using triazolam, they will likely recommend a gradual tapering process to reduce the risk of withdrawal symptoms.

9.        Open Communication:

•          Always maintain open communication with your healthcare provider. Discuss any concerns, side effects, or changes in your condition promptly.

10.      Alternative Treatments:

•          If you experience significant side effects or concerns about the medication, discuss alternative treatments for your condition with your healthcare provider. There are non-pharmacological approaches for managing insomnia and anxiety that may be considered.

It’s crucial to remember that individual responses to medications can vary. What works for one person may not work the same way for another. Therefore, personalized guidance from a healthcare provider is essential to ensure that the medication is used safely and effectively. Your healthcare provider can help you weigh the potential benefits and risks of triazolam in your specific situation and make the best treatment decisions for you.

<

Dr. Oche Otorkpa PG Cert, MPH, PhD

Dr. Oche is a seasoned Public Health specialist who holds a post graduate certificate in Pharmacology and Therapeutics, an MPH, and a PhD both from Texila American University. He is a member of the International Society of Substance Use Professionals and a Fellow of the Royal Society for Public Health in the UK. He authored two books: "The Unseen Terrorist," published by AuthorHouse UK, and "The Night Before I Killed Addiction."
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker